Development Technologies Corp. (DVTC) Research

Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.

Market snapshot

Symbol
DVTC
Price
$5.00
Day change
0.00%
Market cap
$272.5M
52-week range
5-5
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • American Metals Recovery and Recycling Inc. (AMRR)
  • Fideicomiso Irrevocable F/2061 FHipo (BNZIF)
  • Crucial Innovations Corp. (CINV)
  • Chun Can Capital Group (CNCN)
  • FlashZero Corp. (FZRO)
  • ME Renewable Power Corporation (MEPW)
  • New America Energy Corp. (NECA)
  • UHF Logistics Group, Inc. (RGLG)

Open Development Technologies Corp. (DVTC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.